세계의 조직 공학 시장 보고서(2025년)

Tissue engineering is a specialized field within biomedical engineering that combines biological and engineering methodologies. It aims to generate three-dimensional tissue and cellular products both in vivo (within a living organism) and in vitro (outside a living organism) by modifying cell growth conditions and utilizing appropriate cell isolates from donor tissues alongside biocompatible scaffold materials. The primary objective is to restore, repair, maintain, or enhance tissue function by replacing or regenerating damaged tissues, thereby improving human body functions.

Key categories within tissue engineering encompass synthetic scaffold materials, biologically derived scaffold materials, and other methodologies. Synthetic scaffold materials are synthetic polymers composed of fibrous proteins that simulate an extracellular matrix, promoting favorable cellular responses and behaviors in tissue engineering applications. These materials find diverse applications across orthopedics and musculoskeletal treatments, neurology, cardiovascular procedures, skin and integumentary therapies, dental applications, among others. Various end-users including hospitals, clinics, and ambulatory facilities utilize these materials for their respective medical applications.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The tissue engineering market research report is one of a series of new reports from The Business Research Company that provides tissue engineering market statistics, including the tissue engineering industry global market size, regional shares, competitors with a tissue engineering market share, detailed tissue engineering market segments, market trends and opportunities, and any further data you may need to thrive in the tissue engineering industry. This tissue engineering market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The tissue engineering market size has grown rapidly in recent years. It will grow from $15.21 billion in 2024 to $17.33 billion in 2025 at a compound annual growth rate (CAGR) of 13.9%. The growth in the historic period can be attributed to advancements in biomaterials, growing aging population, increasing incidence of chronic diseases, regulatory support for regenerative medicine, rising patient demand for organ transplants.

The tissue engineering market size is expected to see rapid growth in the next few years. It will grow to $29.29 billion in 2029 at a compound annual growth rate (CAGR) of 14.0%. The growth in the forecast period can be attributed to precision medicine approaches, increasing focus on immunomodulation, expanding applications in orthopedics, increased funding and investment, rising prevalence of chronic diseases. Major trends in the forecast period include integration of nanotechnology, 3d cell culture techniques, development of organ-on-a-chip technology, artificial intelligence integration, innovative cell sources.

The forecast of 14.0% growth over the next five years reflects a modest reduction of 0.4% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may pose a significant challenge for the U.S. by restricting access to 3D bioprinting materials and stem cell scaffolds imported from Japan and the Netherlands, potentially slowing regenerative medicine innovation and increasing research and development costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising prevalence of chronic diseases and trauma emergencies is anticipated to drive the growth of the tissue engineering market in the future. Chronic diseases are defined as clinical conditions lasting three months or longer that can typically be managed but not cured, while trauma emergencies refer to physical injuries requiring immediate medical attention due to their sudden onset and severity, such as traumatic brain injuries. Healthcare professionals widely adopt tissue engineering for its numerous benefits in treating chronic disorders and trauma, helping to prevent end-stage treatment failures, including autologous or allograft transplantation, xenotransplantation, and artificial substitutes. For example, a 2023 report by the World Health Organization (WHO), a U.S.-based agency focused on promoting global health and coordinating responses to health emergencies, noted that approximately 2.4 billion people worldwide live with chronic diseases, with significant increases in conditions like diabetes and cardiovascular diseases. This growing prevalence underscores the urgent need for advanced medical treatments, including tissue engineering solutions. Furthermore, the Centers for Disease Control and Prevention (CDC) reported in 2023 that traumatic brain injuries (TBIs) remain a critical issue in the United States, with around 223,000 hospitalizations and 60,000 deaths annually, highlighting the necessity for effective interventions. Consequently, the increasing incidence of chronic illnesses and trauma emergencies is expected to significantly drive growth in the tissue engineering market.

The rising prevalence of cardiovascular disorders is projected to propel the growth of the tissue engineering market in the future. Cardiovascular disorders, or cardiovascular diseases (CVD), represent a class of medical conditions affecting the heart and blood vessels. Tissue engineering provides promising solutions for repairing and regenerating damaged cardiac and vascular tissues. For instance, in September 2024, data published by the British Heart Foundation, a UK-based cardiovascular research charity, indicated that approximately 7.6 million people in the UK are affected by heart and circulatory diseases, with about 4 million males and 3.6 million females living with these conditions. These diseases account for roughly 27% of all deaths in the UK, translating to over 170,000 fatalities annually, or about 480 deaths each day, equating to one death every three minutes. Therefore, the increasing prevalence of cardiovascular disorders is driving the growth of the tissue engineering market.

Technological advancements are a key trend gaining traction in the tissue engineering market. Major companies in this sector are concentrating on research and development to innovate products that offer improved solutions and reinforce their market positions. For instance, in August 2024, CytoNest Inc., a U.S.-based company specializing in scalable 3D cell culture platforms for adherent cell manufacturing, launched its first commercial product: a fiber scaffold designed to optimize cell manufacturing and tissue engineering. This product, known as the CytoSurge 3D fiber scaffold, has applications in cell research, biopharmaceuticals, cell therapeutics, and the development of cultured meat and seafood.

Key companies are strategically forming partnerships and collaborations with start-ups and mid-sized firms in the tissue engineering market to enhance their product and service offerings. These strategic alliances enable companies to expand their existing product portfolios and geographical presence. For example, in June 2023, Regen Lab, a Swiss-based commercial-stage medical technology company focused on the research, development, registration, manufacturing, and commercialization of proprietary tissue engineering products, entered into a collaboration agreement with Long Island University (LIU) and the Dassault Systemes Group (3DS). According to the terms of this agreement, LIU and RegenLab USA will pool resources to establish an industrial innovation accelerator, a new center of excellence dedicated to regenerative medicine and tissue engineering. Long Island University is a U.S.-based educational institution, while Dassault Systemes Group is a France-based software corporation.

In October 2022, Geistlich Pharma, a US-based company specializing in bone, cartilage, and tissue regeneration, completed the acquisition of Lynch Biologics, LLC. The financial specifics of this acquisition were not disclosed. This strategic move serves to bolster Geistlich's existing regenerative product portfolio and augments its growth prospects within the field. Lynch Biologics, the acquired company, is also based in the US and is known for its focus on regenerative medicine and tissue engineering. They specialize in supplying advanced biotechnology products aimed at fostering healing and tissue regeneration.

Major companies operating in the tissue engineering market include Medtronic plc, Zimmer Biomet, Organogenesis Holdings Inc., Integra LifeSciences, Stryker Corporation, DePuy Synthes Companies, B. Braun Melsungen AG, RTI Surgical Inc., AbbVie Inc., Becton Dickinson and Company, Baxter International Inc., BioTime Inc., Vericel Corporation, Smith and Nephew, Athersys Inc., Tissue Regenix Group plc, Xeltis AG, Prellis Biologics, Bit Bio, Be Biopharma Inc., TELA Bio Inc., Orthocell Limited

North America was the largest region in the tissue engineering market in 2024. Asia-Pacific is expected to be the fastest-growing region in the tissue engineering market during the forecast period. The regions covered in the tissue engineering market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the tissue engineering market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The tissue engineering market consists of sales of reparative cells, bioreactive molecules, such as cytokines, growth factors, biomaterials, and bioreactors. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tissue Engineering Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tissue engineering market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tissue engineering ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The tissue engineering market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Synthetic Scaffold Material; Biologically Derived Scaffold Material; Other Types
• 2) By Application: Orthopedics And Musculoskeletal; Neurology; Cardiovascular; Skin And Integumentary; Dental; Other Applications
• 3) By End-User: Hospitals And Clinics; Ambulatory Facilities
• Subsegments:
• 1) By Synthetic Scaffold Material: Polymeric Scaffolds; Ceramic Scaffolds; Composite Scaffolds
• 2) By Biologically Derived Scaffold Material: Natural Polymers; Decellularized Tissues; Hydrogels
• 3) By Other Types: Self-Healing Scaffolds; Smart Scaffolds
• Companies Mentioned: Medtronic plc; Zimmer Biomet; Organogenesis Holdings Inc.; Integra LifeSciences; Stryker Corporation; DePuy Synthes Companies; B. Braun Melsungen AG; RTI Surgical Inc.; AbbVie Inc.; Becton Dickinson and Company; Baxter International Inc.; BioTime Inc.; Vericel Corporation; Smith and Nephew; Athersys Inc.; Tissue Regenix Group plc; Xeltis AG; Prellis Biologics; Bit Bio; Be Biopharma Inc.; TELA Bio Inc.; Orthocell Limited
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Tissue Engineering Market Characteristics

3. Tissue Engineering Market Trends And Strategies

4. Tissue Engineering Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Tissue Engineering Growth Analysis And Strategic Analysis Framework

• 5.1. Global Tissue Engineering PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Tissue Engineering Market Growth Rate Analysis
• 5.4. Global Tissue Engineering Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Tissue Engineering Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Tissue Engineering Total Addressable Market (TAM)

6. Tissue Engineering Market Segmentation

• 6.1. Global Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Synthetic Scaffold Material
• Biologically Derived Scaffold Material
• Other Types
• 6.2. Global Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Orthopedics And Musculoskeletal
• Neurology
• Cardiovascular
• Skin And Integumentary
• Dental
• Other Applications
• 6.3. Global Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Ambulatory Facilities
• 6.4. Global Tissue Engineering Market, Sub-Segmentation Of Synthetic Scaffold Material, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Polymeric Scaffolds
• Ceramic Scaffolds
• Composite Scaffolds
• 6.5. Global Tissue Engineering Market, Sub-Segmentation Of Biologically Derived Scaffold Material, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Natural Polymers
• Decellularized Tissues
• Hydrogels
• 6.6. Global Tissue Engineering Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Self-Healing Scaffolds
• Smart Scaffolds

7. Tissue Engineering Market Regional And Country Analysis

• 7.1. Global Tissue Engineering Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Tissue Engineering Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Tissue Engineering Market

• 8.1. Asia-Pacific Tissue Engineering Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Tissue Engineering Market

• 9.1. China Tissue Engineering Market Overview
• 9.2. China Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Tissue Engineering Market

• 10.1. India Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Tissue Engineering Market

• 11.1. Japan Tissue Engineering Market Overview
• 11.2. Japan Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Tissue Engineering Market

• 12.1. Australia Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Tissue Engineering Market

• 13.1. Indonesia Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Tissue Engineering Market

• 14.1. South Korea Tissue Engineering Market Overview
• 14.2. South Korea Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Tissue Engineering Market

• 15.1. Western Europe Tissue Engineering Market Overview
• 15.2. Western Europe Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Tissue Engineering Market

• 16.1. UK Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Tissue Engineering Market

• 17.1. Germany Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Tissue Engineering Market

• 18.1. France Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Tissue Engineering Market

• 19.1. Italy Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Tissue Engineering Market

• 20.1. Spain Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Tissue Engineering Market

• 21.1. Eastern Europe Tissue Engineering Market Overview
• 21.2. Eastern Europe Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Tissue Engineering Market

• 22.1. Russia Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Tissue Engineering Market

• 23.1. North America Tissue Engineering Market Overview
• 23.2. North America Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Tissue Engineering Market

• 24.1. USA Tissue Engineering Market Overview
• 24.2. USA Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Tissue Engineering Market

• 25.1. Canada Tissue Engineering Market Overview
• 25.2. Canada Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Tissue Engineering Market

• 26.1. South America Tissue Engineering Market Overview
• 26.2. South America Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Tissue Engineering Market

• 27.1. Brazil Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Tissue Engineering Market

• 28.1. Middle East Tissue Engineering Market Overview
• 28.2. Middle East Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Tissue Engineering Market

• 29.1. Africa Tissue Engineering Market Overview
• 29.2. Africa Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Tissue Engineering Market Competitive Landscape And Company Profiles

• 30.1. Tissue Engineering Market Competitive Landscape
• 30.2. Tissue Engineering Market Company Profiles
  • 30.2.1. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Zimmer Biomet Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Organogenesis Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Integra LifeSciences Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Tissue Engineering Market Other Major And Innovative Companies

• 31.1. DePuy Synthes Companies
• 31.2. B. Braun Melsungen AG
• 31.3. RTI Surgical Inc.
• 31.4. AbbVie Inc.
• 31.5. Becton Dickinson and Company
• 31.6. Baxter International Inc.
• 31.7. BioTime Inc.
• 31.8. Vericel Corporation
• 31.9. Smith and Nephew
• 31.10. Athersys Inc.
• 31.11. Tissue Regenix Group plc
• 31.12. Xeltis AG
• 31.13. Prellis Biologics
• 31.14. Bit Bio
• 31.15. Be Biopharma Inc.

32. Global Tissue Engineering Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Tissue Engineering Market

34. Recent Developments In The Tissue Engineering Market

35. Tissue Engineering Market High Potential Countries, Segments and Strategies

• 35.1 Tissue Engineering Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Tissue Engineering Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Tissue Engineering Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer